A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset.


Journal

Cancer research communications
ISSN: 2767-9764
Titre abrégé: Cancer Res Commun
Pays: United States
ID NLM: 9918281580506676

Informations de publication

Date de publication:
23 Jan 2024
Historique:
accepted: 04 01 2024
received: 12 05 2023
revised: 26 09 2023
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: aheadofprint

Résumé

Evidence supports significant interactions among microbes, immune cells, and tumor cells in at least 10-20% of human cancers, emphasizing the importance of further investigating these complex relationships. However, the implications and significance of tumor-related microbes remain largely unknown. Studies have demonstrated the critical roles of host microbes in cancer prevention and treatment responses. Understanding interactions between host microbes and cancer can drive cancer diagnosis and microbial therapeutics (bugs as drugs). Computational identification of cancer-specific microbes and their associations is still challenging due to the high dimensionality and high sparsity of intratumoral microbiome data, which requires large datasets containing sufficient event observations to identify relationships, and the interactions within microbial communities, the heterogeneity in microbial composition, and other confounding effects that can lead to spurious associations. To solve these issues, we present a bioinformatics tool, MEGA, to identify the microbes most strongly associated with 12 cancer types. We demonstrate its utility on a dataset from a consortium of 9 cancer centers in the Oncology Research Information Exchange Network (ORIEN). This package has 3 unique features: species-sample relations are represented in a heterogeneous graph and learned by a graph attention network; it incorporates metabolic and phylogenetic information to reflect intricate relationships within microbial communities; and it provides multiple functionalities for association interpretations and visualizations. We analyzed 2704 tumor RNA-seq samples and MEGA interpreted the tissue-resident microbial signatures of each of 12 cancer types. MEGA can effectively identify cancer-associated microbial signatures and refine their interactions with tumors.

Identifiants

pubmed: 38259095
pii: 733634
doi: 10.1158/2767-9764.CRC-23-0213
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Cankun Wang (C)

OSU, Columbus, OH, United States.

Anjun Ma (A)

OSU, Columbus, OH, United States.

Yingjie Li (Y)

The Ohio State University, Columbus, OH, United States.

Megan E McNutt (ME)

The Ohio State University, Columbus, OH, United States.

Shiqi Zhang (S)

The Ohio State University, Columbus, OH, United States.

Jiangjiang Zhu (J)

The Ohio State University, Columbus, OH, United States.

Rebecca Hoyd (R)

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.

Caroline E Wheeler (CE)

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.

Lary A Robinson (LA)

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

Carlos H F Chan (CHF)

University of Iowa, Iowa City, IA, United States.

Yousef Zakharia (Y)

University of Iowa Hospitals and Clinics, Iowa City, IA, United States.

Rebecca D Dodd (RD)

University of Iowa, Iowa City, IA, United States.

Cornelia M Ulrich (CM)

Huntsman Cancer Institute, Salt Lake City, UT, United States.

Sheetal Hardikar (S)

Huntsman Cancer Institute, Salt Lake City, UT, United States.

Ahmad A Tarhini (AA)

Moffitt Cancer Center, Tampa, Florida, United States.

Eric A Singer (EA)

The Ohio State University Wexner Medical Center, Columbus, OH, United States.

Alexandra P Ikeguchi (AP)

Stephenson Cancer Center of University of Oklahoma, Oklahoma City, OK, United States.

Martin D McCarter (MD)

University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Nicholas Denko (N)

Ohio State University, Columbus, OH, United States.

Gabriel Tinoco (G)

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.

Marium Husain (M)

The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.

Ning Jin (N)

Ohio State University Wexner Medical Center, Columbus, Ohio, United States.

Afaf E G Osman (AEG)

University of Utah, Salt Lake City, United States.

Islam Eljilany (I)

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

Aik Choon Tan (AC)

Huntsman Cancer Institute, Salt Lake City, UT, United States.

Samuel S Coleman (SS)

University of Utah, Salt Lake City, UT, United States.

Louis Denko (L)

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.

Gregory Riedlinger (G)

Rutgers Cancer Institute of New Jersey, New Brunswick, United States.

Bryan P Schneider (BP)

Indiana University Bloomington, Indianapolis, IN, United States.

Daniel Spakowicz (D)

Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.

Qin Ma (Q)

The Ohio State University, Columbus, United States.

Classifications MeSH